Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Craneware Insights Articles
Education
Home
Journey
News & Events
Opportunities
Other
post
Press Releases
Products
Testimonial
Trade Shows
Uncategorized
Upcoming Events
Value Cycle
Webinars
White Papers

Director/ PDMR Shareholding

10 September 2018 – Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, on 7 September purchased a total of 4,848 ordinary shares of 1p each (“Ordinary Shares”) at an average price of 3,081.91 pence per Ordinary Share.

Following the purchase, Mr Neilson holds 3,382,647 Ordinary Shares in the capital of the Company, representing 12.7% per cent. of the Company’s issued share capital.

For further information, please contact:

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO / Craig Preston, CFO

 

Peel Hunt (NOMAD and Joint Broker)

+44 (0)20 7418 8900

Dan Webster/ George Sellar

 

Investec Bank (Joint Broker)

+44 (0) 20 7597 5970

Patrick Robb/ Sebastian Lawrence/ Henry Reast

 

Alma (Financial PR)

+44 (0)208 004 4217

Caroline Forde/ Robyn Fisher/ Josh Royston

 

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

Learn more at www.craneware.com.

Appendix 1

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Keith Neilson

 

2

Reason for the notification

 

a)

Position/Status:

 

Chief Executive Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

 

a)

Name:

Craneware plc

 

b)

LEI:

213800O2CTJ1YFXNXG05

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the financial instrument:

Identification code:

Ordinary Shares

ISIN GB00B2425G68

 

b)

Nature of the transaction:

 

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

3,070p

1,000

 

 

3,085p

3,848

d)

Aggregated price(s) and volume(s):

Price(s)

Volume(s)

3,081.91p

4,848

e)

Date of the Transaction:

 

7 September 2018

f)

Place of the Transaction:

London Stock Exchange (XLON)